Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan thirst provocation test development in healthy volunteers and patients with altered thirst sensation
NL-OMON38159Withdrawn
- Sponsor
- Reinier de Graaf Hospital
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tolvaptan in None and polydipsia (5 arms), sponsored by Reinier de Graaf Hospital. Primary endpoint: Thirst sensation measured by visual analogue scale. Planned start Jun 2012; status: withdrawn.
02
Drugs
tolvaptan
03
Conditions
polydipsia
Beyond the preview
Go deeper on NL-OMON38159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38159.